CSI Market
Sign In | Register

Interpace Biosciences Inc (PDII) Annual Balance Sheets

Annual · GAAP · USD millions
Access PDII quarterly Balance Sheets →
From Interpace Biosciences Inc through Dec 31 2021, shifts in Dec 31 2025's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent2.51
Cash & Short-term Investments2.00
Accounts receivable5.65
Other Current Assets1.75
Total Current Assets9.90
Equipment/Property/Plant Net1.42
Goodwill net0.00
Intangible Assets0.00
Other Assets, Noncurrent22.52
Restricted Cash Current-
Operating Lease Right Of Use Asset1.22
Total Assets33.84
Liabilities
Accounts Payable, Current AC0.98
Employee-related Liabilities, Current AC1.89
Notes Payable, Current NO0.00
Other Liabilities, Current1.57
Disposal Group, Including Discontinued Operation, Liabilities, Current LI0.66
Total Current Liabilities5.10
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent5.62
Operating Lease Liability Noncurrent0.75
Total Liabilities11.48
Stockholders' Equity
Common Stock Value0.41
Treasury Stock Value-2.07
Additional Paid In Capital Common Stock234.83
Retained Earnings / Accumulated Deficit-210.81
Other Equity0.00
Common Stockholder's Equity22.36
Non-controlling interests & other0.00
Total Stockholder's Equity22.36
Liabilities & Stockholder's Equity33.84
4 historic quarters locked

Sign in to unlock the full Interpace Biosciences Inc balance sheet history.

Sign In Create Free Account

About Interpace Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 30, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-013646

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.